52
Views
1
CrossRef citations to date
0
Altmetric
Review

Practical diagnostic approach to uveitis

, &
Pages 449-459 | Published online: 09 Jan 2014

References

  • Channa R, Khurana RN, Speicher MA et al. Diagnostic and therapeutic challenges: panuveitis and optic neuritis. Retina29(7), 1045–1051 (2009).
  • Birnbaum AD, Oh FS, Chakrabarti A, Tessler HH, Goldstein DA. Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch. Ophthalmol.129(4), 409–413 (2011).
  • Gordon LK. Uveitis and neurological diseases. Br. J. Ophthalmol.88(12), 1483–1484 (2004).
  • Kijlstra A. The value of laboratory testing in uveitis. Eye (Lond.).4(Pt 5), 732–736 (1990).
  • Becker MD, Rosenbaum JT. Essential laboratory tests in uveitis. Dev. Ophthalmol.31, 92–108 (1999).
  • Chan CC, Shen D, Tuo J. Polymerase chain reaction in the diagnosis of uveitis. Int. Ophthalmol. Clin.45(2), 41–55 (2005).
  • de Schryver I, Rozenberg F, Cassoux N et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br. J. Ophthalmol.90(7), 852–855 (2006).
  • Herbort CP, Rao NA, Mochizuki M; Members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul. Immunol. Inflamm.17(3), 160–169 (2009).
  • Margolis R. Diagnostic vitrectomy for the diagnosis and management of posterior uveitis of unknown etiology. Curr. Opin. Ophthalmol.19(3), 218–224 (2008).
  • Rothova A, Ooijman F, Kerkhoff F, Van Der Lelij A, Lokhorst HM. Uveitis masquerade syndromes. Ophthalmology108(2), 386–399 (2001).
  • Svozilkova P, Heissigerova J, Brichova M, Kalvodova B, Dvorak J, Rihova E. The role of pars plana vitrectomy in the diagnosis and treatment of uveitis. Eur. J. Ophthalmol.21(1), 89–97 (2011).
  • Yeh S, Faia LJ, Nussenblatt RB. Advances in the diagnosis and immunotherapy for ocular inflammatory disease. Semin. Immunopathol.30(2), 145–164 (2008).
  • Noble J, Hollands H, Forooghian F et al. Evaluating the cost–effectiveness of anterior uveitis investigation by Canadian ophthalmologists. Can. J. Ophthalmol.43(6), 652–657 (2008).
  • Puech C, Gennai S, Pavese P et al. Ocular manifestations of syphilis: recent cases over a 2.5-year period. Graefes. Arch. Clin. Exp. Ophthalmol.248(11), 1623–1629 (2010).
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am. J. Ophthalmol.140(3), 509–516 (2005).
  • Rao NA, Gupta A, Dustin L et al. Frequency of distinguishing clinical features in Vogt–Koyanagi–Harada disease. Ophthalmology117(3), 591–599, 599.e1 (2010).
  • Smith JA, Mackensen F, Sen HN et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology116(8), 1544–1551, 1551.e1 (2009).
  • Foster H, Ramanan AV. ‘The eyes have it!’ The need to improve awareness and access to early ophthalmological screening for juvenile idiopathic arthritis associated uveitis. Rheumatology (Oxford)48(4), 330–331 (2009).
  • Ali A, Samson CM. Seronegative spondyloarthropathies and the eye. Curr. Opin. Ophthalmol.18(6), 476–480 (2007).
  • Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: clinical application of an interferon-γ release assay. Ophthalmology116(7), 1391–1396 (2009).
  • Deuter CM, Kotter I, Wallace GR, Murray PI, Stubiger N, Zierhut M. Behçet’s disease: ocular effects and treatment. Prog. Retin. Eye Res.27(1), 111–136 (2008).
  • Tugal-Tutkun I, Otuk-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int. Ophthalmol.30(5), 559–565 (2010).
  • Qian Y, Acharya NR. Juvenile idiopathic arthritis-associated uveitis. Curr. Opin. Ophthalmol.21(6), 468–472 (2010).
  • Sijssens KM, Los LI, Rothova A et al. Long-term ocular complications in aphakic versus pseudophakic eyes of children with juvenile idiopathic arthritis-associated uveitis. Br. J. Ophthalmol.94(9), 1145–1149 (2010).
  • Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology117(7), 1436–1441 (2010).
  • Hovakimyan A, Baglivo E, Cunningham ET Jr. Fuchs uveitis syndrome in the developing world. Int. Ophthalmol. Clin.50(2), 145–153 (2010).
  • Holland GN, Denove CS, Yu F. Chronic anterior uveitis in children: clinical characteristics and complications. Am. J. Ophthalmol.147(4), 667–678 e665 (2009).
  • Cassidy J, Kivlin J, Lindsley C, Nocton J; Section on Rheumatology; Section on Ophthalmology. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics117(5), 1843–1845 (2006).
  • Zaidi AA, Ying GS, Daniel E et al. Hypopyon in patients with uveitis. Ophthalmology117(2), 366–372 (2010).
  • Gupta A, Bansal R, Gupta V, Sharma A, Bambery P. Ocular signs predictive of tubercular uveitis. Am. J. Ophthalmol.149(4), 562–570 (2010).
  • Huang C, Park S, Castellarin AA, Pieramici DJ, Cunningham ET Jr. Diagnostic and therapeutic challenges. Retina27(3), 385–390 (2007).
  • Antcliff RJ, Stanford MR, Chauhan DS et al. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology107(3), 593–599 (2000).
  • Yeh S, Forooghian F, Wong WT et al. Fundus autofluorescence imaging of the white dot syndromes. Arch. Ophthalmol.128(1), 46–56 (2010).
  • Iannetti L, Accorinti M, Liverani M, Caggiano C, Abdulaziz R, Pivetti-Pezzi P. Optical coherence tomography for classification and clinical evaluation of macular edema in patients with uveitis. Ocul. Immunol. Inflamm.16(4), 155–160 (2008).
  • Holder GE, Robson AG, Pavesio C, Graham EM. Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br. J. Ophthalmol.89(6), 709–718 (2005).
  • Stubiger N, Besch D, Deuter CM, Zierhut M, Kotter I. Multifocal ERG changes in patients with ocular Behçet’s disease during therapy with interferon α2a. Adv. Exp. Med. Biol.528, 529–532 (2003).
  • Guly CM, Forrester JV. Investigation and management of uveitis. BMJ341, c4976 (2010).
  • Harper TW, Miller D, Schiffman JC, Davis JL. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am. J. Ophthalmol.147(1), 140–147 e142 (2009).
  • Rothova A, de Boer JH, Ten Dam-van Loon NH et al. Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology115(2), 306–311 (2008).
  • Bodaghi B, LeHoang P. Testing ocular fluids in uveitis. Ophthalmol. Clin. North Am.15(3), 271–279 (2002).
  • de Groot-Mijnes JD, de Visser L, Zuurveen S et al. Identification of new pathogens in the intraocular fluid of patients with uveitis. Am. J. Ophthalmol.150(5), 628–636 (2010).
  • De Groot-Mijnes JD, Rothova A, Van Loon AM et al. Polymerase chain reaction and Goldmann–Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am. J. Ophthalmol.141(2), 313–318 (2006).
  • Van Gelder RN. Has the polymerase chain reaction come of age for ophthalmology? Am. J. Ophthalmol.147(1), 5–7 (2009).
  • Sudharshan S, Ganesh SK, Biswas J. Current approach in the diagnosis and management of posterior uveitis. Indian J. Ophthalmol.58(1), 29–43 (2010).
  • Margolis R, Brasil OF, Lowder CY et al. Vitrectomy for the diagnosis and management of uveitis of unknown cause. Ophthalmology114(10), 1893–1897 (2007).
  • Huhtinen M, Karma A. HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br. J. Ophthalmol.84(4), 413–416 (2000).
  • Forooghian F, Gupta R, Wong DT, Derzko-Dzulynsky L. Anterior uveitis investigation by Canadian ophthalmologists: insights from the Canadian National Uveitis Survey. Can. J. Ophthalmol.41(5), 576–583 (2006).
  • Amaratunge BC, Camuglia JE, Hall AJ. Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients. Clin. Exp. Ophthalmol.38(1), 68–74 (2010).
  • Singleton EM, Hutson SE. Anterior uveitis, inflammatory bowel disease and ankylosing spondylitis in a HLA-B27-positive woman. South Med. J.99(5), 531–533 (2006).
  • Pato E, Banares A, Jover JA et al. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. J. Rheumatol.27(9), 2198–2202 (2000).
  • Sheehan NJ. The ramifications of HLA-B27. J. R. Soc. Med.97(1), 10–14 (2004).
  • Zamecki KJ, Jabs DA. HLA typing in uveitis: use and misuse. Am. J. Ophthalmol.49(2), 189–193.e2 (2010).
  • Khairallah M, Chee SP, Rathinam SR, Attia S, Nadella V. Novel infectious agents causing uveitis. Int. Ophthalmol.30(5), 465–483 (2010).
  • Liekfeld A, Schweig F, Jaeckel C, Wernecke KD, Hartmann C, Pleyer U. Intraocular antibody production in intraocular inflammation. Graefes. Arch. Clin. Exp. Ophthalmol.238(3), 222–227 (2000).
  • Wong M, Goldstein DA, Tessler HH. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am. J. Ophthalmol.147(6), 1106–1107; author reply 1107–1108 (2009).
  • Visser N, Rothova A, de Groot-Mijnes JD, de Visser L. Searching for intraocular antibody production against parvovirus B19, mumps virus and measles virus in patients with intermediate and posterior uveitis. Br. J. Ophthalmol.93(6), 841–842 (2009).
  • Van der Lelij A, Rothova A. Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? Br. J. Ophthalmol.81(11), 976–979 (1997).
  • Lobo A, Lightman S. Vitreous aspiration needle tap in the diagnosis of intraocular inflammation. Ophthalmology110(3), 595–599 (2003).
  • de Groot-Mijnes JD, de Visser L, Rothova A, Schuller M, van Loon AM, Weersink AJ. Rubella virus is associated with fuchs heterochromic iridocyclitis. Am. J. Ophthalmol.141(1), 212–214 (2006).
  • Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am. J. Ophthalmol.138(1), 46–54 (2004).
  • Davatchi F, Shahram F, Chams-Davatchi C et al. Behçet’s disease: from East to West. Clin. Rheumatol.29(8), 823–833 (2010).
  • Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Beçcet’s disease in the US: a population-based study. Arthritis Rheum.61(5), 600–604 (2009).
  • Mackensen F, Smith JR, Rosenbaum JT. Enhanced recognition, treatment and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology114(5), 995–999 (2007).
  • Levinson RD. Tubulointerstitial nephritis and uveitis syndrome. Int. Ophthalmol. Clin.48(3), 51–59 (2008).
  • Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin. Respir. Crit. Care Med.31(4), 452–462 (2010).
  • Wakefield D, Zierhut M. Controversy: ocular sarcoidosis. Ocul. Immunol. Inflamm.18(1), 5–9 (2010).
  • Asukata Y, Ishihara M, Hasumi Y et al. Guidelines for the diagnosis of ocular sarcoidosis. Ocul. Immunol. Inflamm.16(3), 77–81 (2008).
  • Cowan CL Jr. Review for disease of the year: differential diagnosis of ocular sarcoidosis. Ocul. Immunol. Inflamm.18(6), 442–451 (2010).
  • Takase H, Shimizu K, Yamada Y, Hanada A, Takahashi H, Mochizuki M. Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis. Jpn J. Ophthalmol.54(6), 529–536 (2010).
  • Kawaguchi T, Hanada A, Horie S, Sugamoto Y, Sugita S, Mochizuki M. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J. Ophthalmol.51(2), 121–126 (2007).
  • Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv. Ophthalmol.46(3), 195–208 (2001).
  • Villanueva-Mendoza C, Arellanes-Garcia L, Cubas-Lorenzo V, Jimenez-Martinez MC, Flores-Suarez LF, Zenteno JC. Familial case of blau syndrome associated with a CARD15/NOD2 mutation. Ophthalmic. Genet.31(3), 155–158 (2010).
  • Rolando I, Vilchez G, Olarte L et al. Brucellar uveitis: intraocular fluids and biopsy studies. Int. J. Infect. Dis.13(5), e206–e211 (2009).
  • Kaiser PK, Lowder CY, Sullivan P et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am. J. Ophthalmol.133(4), 499–505 (2002).
  • Nolle B, Coners H, Duncker G. ANCA in ocular inflammatory disorders. Adv. Exp. Med. Biol.336, 305–307 (1993).
  • Gallagher MJ, Cervantes-Castaneda RA, Bhat P, Yilmaz T, Foster CS. Primary intraocular lymphoma: another great masquerader. Eur. J. Ophthalmol.18(4), 567–571 (2008).
  • Babu BM, Rathinam SR. Intermediate uveitis. Indian J. Ophthalmol.58(1), 21–27 (2010).
  • Bonfioli AA, Damico FM, Curi AL Orefice F. Intermediate uveitis. Semin. Ophthalmol.20(3), 147–154 (2005).
  • Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult. Scler.10(5), 575–581 (2004).
  • Inoue K, Numaga J, Joko S et al. A case of multiple sclerosis with granulomatous uveitis in Japan – use of the antilipoarabinomannan (LAM)-B test in differential diagnosis. Am. J. Ophthalmol.131(4), 524–526 (2001).
  • Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Curr. Opin. Ophthalmol.16(5), 315–320 (2005).
  • Dodds EM, Holland GN, Stanford MR et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am. J. Ophthalmol.146(6), 856–865 e852 (2008).
  • Johnston RL, Tufail A, Lightman S et al. Retinal and choroidal biopsies are helpful in unclear uveitis of suspected infectious or malignant origin. Ophthalmology111(3), 522–528 (2004).
  • Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am. J. Trop. Med. Hyg.82(3), 464–465 (2010).
  • Wensing B, de Groot-Mijnes JD, Rothova A. Necrotizing and nonnecrotizing variants of herpetic uveitis with posterior segment involvement. Arch. Ophthalmol.129(4), 403–408 (2011).
  • Pavesio CE, Mitchell SM, Barton K, Schwartz SD, Towler HM, Lightman S. Progressive outer retinal necrosis (PORN) in AIDS patients: a different appearance of varicella-zoster retinitis. Eye (Lond.)9(Pt 3), 271–276 (1995).
  • Basu S, Das T. Pitfalls in the management of TB-associated uveitis. Eye (Lond.)24(11), 1681–1684 (2010).
  • Rocha R, Martins S, Ferreira C, Antunes H. A presumed tubercular choroiditis based on interferon-γ release assay and response to therapy. Pediatr. Infect. Dis. J.29(9), 891–892 (2010).
  • Hughes EH, Guzowski M, Simunovic MP, Hunyor AP, McCluskey P. Syphilitic retinitis and uveitis in HIV-positive adults. Clin. Exp. Ophthalmol.38(9), 851–856 (2010).
  • Yasuno Y, Okamoto F, Kawana K, Yatagai T, Oshika T. Investigation of multifocal choroiditis with panuveitis by three-dimensional high-penetration optical coherence tomography. J. Biophotonics2(6–7), 435–441 (2009).
  • Levinson RD, Brezin A, Rothova A, Accorinti M, Holland GN. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am. J. Ophthalmol.141(1), 185–187 (2006).
  • Shah KH, Levinson RD, Yu F et al. Birdshot chorioretinopathy. Surv. Ophthalmol.50(6), 519–541 (2005).
  • Monnet D, Brezin AP, Holland GN et al. Longitudinal cohort study of patients with birdshot chorioretinopathy. I. Baseline clinical characteristics. Am. J. Ophthalmol.141(1), 135–142 (2006).
  • Pahk PJ, Todd DJ, Blaha GR et al. Intravascular lymphoma masquerading as Vogt–Koyanagi–Harada syndrome. Ocul. Immunol. Inflamm.16(3), 123–126 (2008).
  • Molina Garrido MJ, Guillen Ponce C, Escolano Hortelano CM, Sabin Dominguez MP, Mora Rufete A, Carrato Mena A. Malignant uveitis masking a lymphocytic lymphoma. Clin. Transl. Oncol.8(11), 835–836 (2006).
  • Levy-Clarke GA, Chan CC, Nussenblatt RB. Diagnosis and management of primary intraocular lymphoma. Hematol. Oncol. Clin. North Am.19(4), 739–749, viii (2005).
  • Davis JL, Miller DM, Ruiz P. Diagnostic testing of vitrectomy specimens. Am. J. Ophthalmol.140(5), 822–829 (2005).
  • Damico FM, Kiss S, Young LH. Sympathetic ophthalmia. Semin. Ophthalmol.20(3), 191–197 (2005).
  • Bansal R, Gupta V, Gupta A. Current approach in the diagnosis and management of panuveitis. Indian J. Ophthalmol.58(1), 45–54 (2010).
  • Castiblanco CP, Adelman RA. Sympathetic ophthalmia. Graefes. Arch. Clin. Exp. Ophthalmol.247(3), 289–302 (2009).
  • Kilmartin DJ, Dick AD, Forrester JV. Sympathetic ophthalmia risk following vitrectomy: should we counsel patients? Br. J. Ophthalmol.84(5), 448–449 (2000).
  • Fang W, Yang P. Vogt–koyanagi–harada syndrome. Curr. Eye Res.33(7), 517–523 (2008).
  • Bordaberry MF. Vogt–Koyanagi–Harada disease: diagnosis and treatments update. Curr. Opin. Ophthalmol.21(6), 430–435 (2010).
  • Kim BJ, Do DV, Nguyen QD, Arevalo F, Van Gelder RN. Diagnostic and therapeutic challenges. Acute onset panuveitis. Retina30(2), 364–368 (2010).
  • Marcus EI, Do DV, Shah SM, Nguyen QD, Biswas J, Levinson R. Diagnostic and therapeutic challenges. Granulomatous panuveitis. Retina28(10), 1544–1549 (2008).
  • Van Gelder RN. Ocular pathogens for the twenty-first century. Am. J. Ophthalmol.150(5), 595–597 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.